These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19455425)

  • 41. [Neuropsychological impairment in human immunodeficiency virus-positive children].
    Millana-Cuevas LC; Portellano JA; Martinez-Arias R
    Rev Neurol; 2007 Mar 16-31; 44(6):366-74. PubMed ID: 17385174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropsychological performance in patients with asymptomatic HIV-1 infection.
    Martínez-Banfi M; Vélez JI; Perea MV; García R; Puentes-Rozo PJ; Mebarak Chams M; Ladera V
    AIDS Care; 2018 May; 30(5):623-633. PubMed ID: 29411628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change.
    Cysique LA; Franklin D; Abramson I; Ellis RJ; Letendre S; Collier A; Clifford D; Gelman B; McArthur J; Morgello S; Simpson D; McCutchan JA; Grant I; Heaton RK; ;
    J Clin Exp Neuropsychol; 2011 Jun; 33(5):505-22. PubMed ID: 21391011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of HIV-associated neuropsychological impairment on everyday functioning.
    Heaton RK; Marcotte TD; Mindt MR; Sadek J; Moore DJ; Bentley H; McCutchan JA; Reicks C; Grant I;
    J Int Neuropsychol Soc; 2004 May; 10(3):317-31. PubMed ID: 15147590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric HIV infection: a neuropsychological and educational challenge.
    Armstrong FD; Seidel JF; Swales TP
    J Learn Disabil; 1993 Feb; 26(2):92-103. PubMed ID: 7681864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans.
    Chartier M; Crouch PC; Tullis V; Catella S; Frawley E; Filanosky C; Carmody T; McQuaid J; Lampiris H; Wong JK
    J Int Assoc Provid AIDS Care; 2015; 14(3):197-201. PubMed ID: 25487428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.
    Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):83-92. PubMed ID: 28284004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV.
    Perry W; Carlson MD; Barakat F; Hilsabeck RC; Schiehser DM; Mathews C; Hassanein TI
    AIDS; 2005 Oct; 19 Suppl 3():S79-84. PubMed ID: 16251832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).
    Milanini B; Ciccarelli N; Fabbiani M; Baldonero E; Limiti S; Gagliardini R; Borghetti A; D'Avino A; Mondi A; Colafigli M; Cauda R; Di Giambenedetto S
    Clin Neuropsychol; 2016; 30(sup1):1457-1468. PubMed ID: 27180611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropsychological Assessment: Past and Future.
    Casaletto KB; Heaton RK
    J Int Neuropsychol Soc; 2017 Oct; 23(9-10):778-790. PubMed ID: 29198281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study.
    Brinkman TM; Krasin MJ; Liu W; Armstrong GT; Ojha RP; Sadighi ZS; Gupta P; Kimberg C; Srivastava D; Merchant TE; Gajjar A; Robison LL; Hudson MM; Krull KR
    J Clin Oncol; 2016 Apr; 34(12):1358-67. PubMed ID: 26834063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of baseline neuropsychological function and progression of illness over 4 years in HIV-seropositive individuals.
    Silberstein CH; O'Dowd MA; Schoenbaum EE; Friedland GH; Chartock P; Feiner C; McKegney FP
    Psychosomatics; 1993; 34(6):502-5. PubMed ID: 8284340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
    Robinson-Papp J; Byrd D; Mindt MR; Oden NL; Simpson DM; Morgello S;
    Arch Neurol; 2008 Aug; 65(8):1096-101. PubMed ID: 18695060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017.
    Wilson SJ; Baxendale S; Barr W; Hamed S; Langfitt J; Samson S; Watanabe M; Baker GA; Helmstaedter C; Hermann BP; Smith ML
    Epilepsia; 2015 May; 56(5):674-81. PubMed ID: 25779625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.
    Weber E; Blackstone K; Woods SP
    Neuropsychol Rev; 2013 Mar; 23(1):81-98. PubMed ID: 23417497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of social support on cognitive symptom burden in HIV/AIDS.
    Atkins JH; Rubenstein SL; Sota TL; Rueda S; Fenta H; Bacon J; Rourke SB
    AIDS Care; 2010 Jul; 22(7):793-802. PubMed ID: 20635243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?
    Muñoz-Moreno JA; Fumaz CR; Prats A; Ferrer MJ; Negredo E; Pérez-Alvarez N; Moltó J; Gómez G; Garolera M; Clotet B
    J Neurovirol; 2010 May; 16(3):208-18. PubMed ID: 20450380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depressive symptoms and neurocognitive performance among HIV-infected women.
    Fialho RM; Pereira M; Mendonça N; Ouakinin S
    Women Health; 2013; 53(2):117-34. PubMed ID: 23517511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors.
    Koenig N; Fujiwara E; Gill MJ; Power C
    Can J Neurol Sci; 2016 Jan; 43(1):157-62. PubMed ID: 26635008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.